Federal Agency · Defense Health Agency Contracting Activity - DHACA
DoW Vision, Clinical Trial Award
Last updated: November 8, 2026
Posted May 5, 2026
- Who can apply
- See eligibility below
- Amount
- Not specified — see source
- Deadline
- November 12, 2026 · 3 days remaining
- Where
- Nationwide
- Status
- Closing soon
Summary
The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas. Distinctive Features: · For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline.
In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, in order for the CTA application to be considered for funding. Refer to Attachment 7: Regulatory Strategy for further details. · Scored peer review criteria include Clinical Impact; Research Strategy and Feasibility; Recruitment, Accrual, Retention; Regulatory Strategy and Transition Plan; Statistical Plan and Data Analysis; Ethical Considerations; Personnel and Communication. · Programmatic review criteria include adherence to the intent of the CTA, contribution to program portfolio, relative impact and relevance to military health. https://cdmrp.health.mil/pubs/press/2026/vrppreann
Focus area
- Funded by Army
NAICS: 541715, 336992
Award details
Applications close on November 12, 2026 (3 days remaining).
Categories
Not categorized
Grants.gov ↗·Last verified November 8, 2026
Similar grants
- Balanced Prosecution of Transnational Organized Crime CasesBureau of International Narcotics-Law Enforcement · closes November 9, 2026
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)National Institutes of Health · closes November 9, 2026
- Fiscal Year (FY) 2026 Funding Opportunity for Indian Tribes and Intertribal Consortia for Nonpoint Source Management Grants Under Clean Water Act Section 319Environmental Protection Agency · closes November 9, 2026
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)National Institutes of Health · closes November 9, 2026
- Capacity Building Grants for Non-Land-Grant Colleges of Agriculture ProgramNational Institute of Food and Agriculture · closes November 10, 2026
- PFE: Research Initiation in Engineering Formation (PFE: RIEF)U.S. National Science Foundation · closes November 10, 2026
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)National Institutes of Health · closes November 10, 2026
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)National Institutes of Health · closes November 10, 2026
